EligibleTrials

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients

Recruiting · NCT05699018 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Angers

View the official record on ClinicalTrials.gov →
NASH

Interventions studied

eLIFT

What this trial is about

The primary objective of the SOPRANO study is to compare two blood fibrosis tests, the eLIFT and the FibroMeter, for the screening of advanced liver fibrosis in patients with NAFLD and/or ALD from primary care centers.

Who can take part

Age range
40 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

13 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.